Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gammaplex 5% in Pediatric PID
NCT01289847Phase 4Completed
- Sponsor
- Bio Products Laboratory
- Start
- Mar 2011
- Primary completion
- Apr 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 4 trial of intravenous immunoglobulin G in primary immunodeficiency disease (PID), sponsored by Bio Products Laboratory. Started Mar 2011; status: completed.
02
Drugs
intravenous immunoglobulin G
03
Conditions
primary immunodeficiency disease (PID)
Beyond the preview
Go deeper on NCT01289847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01289847.